Bontai Biological Engineering (Shenzhen) Co., Ltd., founded in July 2012, is a high-tech enterprise centered on synthetic biology technologies such as biological enzyme catalysis, integrating research and development, production, and sales. The company's main products cover six series: coenzyme series, natural product series, sugar substitute series, cosmetics series, dietary supplement series, and pharmaceutical intermediate series.

 As the industry leader in the field, its products are widely used in nutrition and health, biomedicine, medical aesthetics and daily chemical products, and green agriculture. Bangtai Biotech, as the pioneer of the NMN industry, adheres to its mission. It possesses the world's first whole-enzyme technology and has taken the lead in becoming an independent innovator in the series of coenzyme products. To date, it has applied for more than 200 domestic and international patents, including 190 invention patents. It has undertaken more than 3 provincial and municipal key science and technology projects, and established the first provincial-level coenzyme engineering technology research center in China and the only one in Guangdong Province.

 Bontai Biotech will leverage its advantages in industrializing green, low-carbon, and high-value-added biotechnology, collaborate with domestic and international research institutions and upstream and downstream partners to build an industrial ecosystem, continue to lead the synthetic biology industry, and create a healthier and better life for humanity.

 Corporate website: https://www.bontac-bio.com/en/